CAR T therapy beyond cancer: the evolution of a living drug
Parker Institute for Cancer Immunotherapy · University of Pennsylvania · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
463
total citations
- FWCI
- 100.76
- Percentile
- 100%
- References
- 105
Citations per year
Authors
5- DBDaniel BakerCorresponding
Parker Institute for Cancer Immunotherapy, University of Pennsylvania
- ZAZoltàn Arany
Cardiovascular Institute of the South, University of Pennsylvania
- JAJoseph A. Baur
University of Pennsylvania
- JAJonathan A. Epstein
California Institute for Regenerative Medicine, Cardiovascular Institute of the South, University of Pennsylvania
- CHCarl H. June
Parker Institute for Cancer Immunotherapy, University of Pennsylvania
Topics & keywords
Topics
Keywords
- Chimeric antigen receptor
- Cancer therapy
- Medicine
- Cancer
- Targeted therapy
- Disease
- CAR T-cell therapy
- Oncology
No related works found for this paper.